Methods of treating Parkinson's disease using viral vectors
US9492415B2 · kind B2 · utility
15Cited by
12References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2012 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Oct 28, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y401/01028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of delivering viral vectors, particularly recombinant adeno-associated virus (rAAV) virions, to the central nervous system (CNS) using convection enhanced delivery (CED) are provided. The rAAV virions include a nucleic acid sequence encoding a therapeutic polypeptide. The methods can be used for treating CNS disorders such as for treating Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.